Growth Metrics

Opus Genetics (IRD) Non Operating Income (2022 - 2024)

Opus Genetics (IRD) has disclosed Non Operating Income for 6 consecutive years, with $6.7 million as the latest value for Q4 2021.

  • On a quarterly basis, Non Operating Income changed N/A to $6.7 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$157000.0, a N/A change, with the full-year FY2022 number at -$14000.0, up 91.08% from a year prior.
  • Non Operating Income was $6.7 million for Q4 2021 at Opus Genetics, up from $1.2 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.7 million in Q4 2021 to a low of $6.7 million in Q4 2021.